EUVIMEDEUVIMED entdecken
Open Access

Point prevalence of metabolic syndrome in HIV positive patients

Shazia Hamid, Ashima Badyal, Vishali Sumberia

Journal of Family Medicine and Primary Care · 2024-04 · 13 (4) · 1328-1332

DOI: 10.4103/jfmpc.jfmpc_1237_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Family Medicine and Primary Care, online erschienen am 22.04.2024. Verfasst von Shazia Hamid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, GMC, Jammu, J and K, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A BSTRACT Introduction: Human immunodeficiency virus (HIV)-related morbidity and mortality have declined over time, but this increased longevity may lead to the development of other diseases, which may further manifest as the metabolic syndrome (MS).

Method

To find out the point prevalence of MS in HIV positive patients, a cross-sectional prospective observational study was conducted on 200 patients who approached ART plus Centre of Government Medical College and Hospital Jammu, including 50 symptomatic patients HIV negative as controls.

Results

The mean age group in MS was 37.85 ± 6.61. Males consisted of 55% (110) and females consisted of 45% (90). The overall prevalence of MS was 13.5%, with prevalence in males being 16.3% and in females 10%. Patients receiving first line highly active antiretroviral therapy (HAART) showed a 24% prevalence, while that of second line HAART showed a 14% prevalence. Central obesity (47.3%) was the most common component of MS followed by hyperglycemia (43.3%), hypertriglyceridemia (38.6%), and low high density cholesterol (HDL-C) level (38.6%). Out of 84 males with MS, 94% (79) males were having hypertriglyceridemia, 88% (74) were hypertensive, and 72% (60) were having FBS >=100. Out of 66 females with MS, 100% (66) females had central obesity and 88% (58) had hypertriglyceridemia and low HDL-C levels.

Conclusion

The metabolic complications as a result of treatment with HAART leave HIV patients at a risk of developing cardiovascular disease and diabetes in spite of improvements in morbidity and mortality. Risk factors like central obesity, hypertension, hyperglycemia, and hypertriglyceridemia should be taken into consideration well before to prevent the add-on effect of developing MS.

Schlagwörter

Stichwörter der Autor:innen

FBS (Fasting blood sugar)HAART (highly active antiretroviral therapy)HDL-C (high density cholesterol)human immunodeficiency virus

Autor:innen und Institutionen

  • Department of Medicine, GMC, Jammu, J and K, India.
  • Department of Biochemistry, GMC, Jammu, J and K, India.
  • Department of General Medicine, GMC, Jammu, J and K, India.

Zitieren

APA

Hamid, S., Badyal, A., & Sumberia, V. (2024). Point prevalence of metabolic syndrome in HIV positive patients. Journal of Family Medicine and Primary Care, 13(4), 1328-1332. https://doi.org/10.4103/jfmpc.jfmpc_1237_23

Vancouver

Hamid S, Badyal A, Sumberia V. Point prevalence of metabolic syndrome in HIV positive patients. Journal of Family Medicine and Primary Care. 2024;13(4):1328-1332. doi:10.4103/jfmpc.jfmpc_1237_23

BibTeX
@article{Hamid2024,
  author = {Hamid, Shazia and Badyal, Ashima and Sumberia, Vishali},
  title = {Point prevalence of metabolic syndrome in HIV positive patients},
  journal = {Journal of Family Medicine and Primary Care},
  year = {2024},
  volume = {13},
  number = {4},
  pages = {1328--1332},
  doi = {10.4103/jfmpc.jfmpc_1237_23}
}
Kostenlos starten →